Skip To Main Content
Signe Sørensen Torekov on Muck Rack

Signe Sørensen Torekov

As seen in: Nature, Wiley Online Library
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Signe Sørensen

Contact Signe Sørensen, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Effects of exercise and liraglutide on vascular health and inflammation during weight loss maintenance: a prespecified secondary analysis of the S-LiTE trial

|
By Rasmus Michael Sandsdal, Julie Jørgensen, Christian Juhl, Lisa Olsen, Sarah Byberg, Lasse Gliemann, Bente M. Stallknecht, Jens Juul Holst, Jens Dahlgaard Hove, Thomas Bandholm, Kirstine Nyvold Bojsen-Møller, Sten Madsbad, Joachim Størling, Else Marie Bladbjerg, Charalambos Antoniades, Signe Sørensen Torekov, Joachim Holt, Roopameera Thirumathyam
| Nature Verified
Abstract Obesity and inactivity are linked to endothelial dysfunction and atherosclerosis. In this secondary analysis of the S-LiTE trial (ClinicalTrials.gov identifier: NCT04122716; EudraCT identifier: 2015–005585-32), 130 adults with obesity completed a diet-induced weight loss plan, followed by randomization to weight maintenance with exercise and/or liraglutide for 52 weeks.
Open in Who Shared Issue with article?

Treat to target in weight management with semaglutide: Real‐world evidence from an eHealth clinic

|
By Signe Sørensen Torekov, Henrik Gudbergsen, Søren Seier, Kine Stamp-Larsen
| Wiley Online Library Verified
CONFLICT OF INTEREST STATEMENT SS and HG are employees at Embla ApS and have stock options at Embla ApS. KSL is a former employee at Embla ApS. SBK's salary is funded by Danish Cardiovascular Academy, which is funded by the Novo Nordisk Foundation and The Danish Heart Foundation. SST reports research grants, honoraria for lectures, and membership on an advisory panel for Novo Nordisk, a research grant from Embla ApS, and honoraria for lectures from Merck and Ferring.
Open in Who Shared Issue with article?

Primary weight loss failure after Roux-en-Y gastric bypass is characterized by impaired gut-hormone mediated regulation of food intake - International Journal of Obesity

|
By Carsten Dirksen, Signe Sørensen Torekov, Niels Grarup, Torben Frøstrup Hansen, Jens Juul Holst, Kirstine Nyvold Bojsen-Møller, Maria Saur Svane
| Nature Verified
Abstract After Roux-en-Y gastric bypass (RYGB) a subset of patients never obtain excess BMI loss (EBMIL) > 50% and are categorized as having primary weight loss (WL) failure. We hypothesized that postprandial concentrations of glucagon-like peptide 1 (GLP-1) and peptide YY (PYY) would be lower in patients with primary WL failure compared with patients with successfully maintained WL.
Open in Who Shared Issue with article?
See all 4 articles